189 related articles for article (PubMed ID: 16180239)
41. Genetic modification of hepatocytes towards hepatocyte transplantation and liver tissue engineering.
Kuge H; Ohashi K; Yokoyama T; Kanehiro H; Hisanaga M; Koyama F; Bumgardner GL; Kosai K; Nakajima Y
Cell Transplant; 2006; 15(1):1-12. PubMed ID: 16700325
[TBL] [Abstract][Full Text] [Related]
42. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model.
Frühauf NR; Oldhafer KJ; Höltje M; Kaiser GM; Frühauf JH; Stavrou GA; Bader A; Broelsch CE
Surgery; 2004 Jul; 136(1):47-56. PubMed ID: 15232539
[TBL] [Abstract][Full Text] [Related]
43. Control of hepatic differentiation via cellular aggregation in an alginate microenvironment.
Maguire T; Davidovich AE; Wallenstein EJ; Novik E; Sharma N; Pedersen H; Androulakis IP; Schloss R; Yarmush M
Biotechnol Bioeng; 2007 Oct; 98(3):631-44. PubMed ID: 17390383
[TBL] [Abstract][Full Text] [Related]
44. Functional modulation of ES-derived hepatocyte lineage cells via substrate compliance alteration.
Li L; Sharma N; Chippada U; Jiang X; Schloss R; Yarmush ML; Langrana NA
Ann Biomed Eng; 2008 May; 36(5):865-76. PubMed ID: 18266108
[TBL] [Abstract][Full Text] [Related]
45. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture.
Lee PJ; Hung PJ; Lee LP
Biotechnol Bioeng; 2007 Aug; 97(5):1340-6. PubMed ID: 17286266
[TBL] [Abstract][Full Text] [Related]
46. Three-dimensional culture of porcine fetal liver cells for a bioartificial liver.
Ehashi T; Ohshima N; Miyoshi H
J Biomed Mater Res A; 2006 Apr; 77(1):90-6. PubMed ID: 16355413
[TBL] [Abstract][Full Text] [Related]
47. Analysis of amino acid supplementation effects on hepatocyte cultures using flux balance analysis.
Yang H; Roth CM; Ierapetritou MG
OMICS; 2011; 15(7-8):449-60. PubMed ID: 21410329
[TBL] [Abstract][Full Text] [Related]
48. Challenging small human hepatocytes with opiates: further characterization of a novel prototype bioartificial liver.
Wurm M; Woess C; Libiseller K; Beer B; Pavlic M
Tissue Eng Part A; 2010 Mar; 16(3):807-13. PubMed ID: 19778170
[TBL] [Abstract][Full Text] [Related]
49. Progress in bioreactors of bioartificial livers.
Yu CB; Pan XP; Li LJ
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
[TBL] [Abstract][Full Text] [Related]
50. Characterization of a hollow fiber bioartificial liver device.
Abu-Absi SF; Seth G; Narayanan RA; Groehler K; Lai P; Anderson ML; Sielaff T; Hu WS
Artif Organs; 2005 May; 29(5):419-22. PubMed ID: 15854219
[TBL] [Abstract][Full Text] [Related]
51. A rational design approach for amino acid supplementation in hepatocyte culture.
Yang H; Roth CM; Ierapetritou MG
Biotechnol Bioeng; 2009 Aug; 103(6):1176-91. PubMed ID: 19422042
[TBL] [Abstract][Full Text] [Related]
52. Novel membranes and surface modification able to activate specific cellular responses.
De Bartolo L; Morelli S; Piscioneri A; Lopez LC; Favia P; d'Agostino R; Drioli E
Biomol Eng; 2007 Feb; 24(1):23-6. PubMed ID: 16914370
[TBL] [Abstract][Full Text] [Related]
53. Hepatocyte function during experimental use of a bioartificial liver.
Papadimitriou D; Arkadopoulos N; Kouskouni E; Tsarouxa N; Demesticha T; Kousi T; Drakopoulou M; Mitrou S; Vassileiou J; Katsorhis T; Patargias T
Transplant Proc; 2004; 36(6):1741-3. PubMed ID: 15350467
[TBL] [Abstract][Full Text] [Related]
54. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets.
Ohashi K; Yokoyama T; Yamato M; Kuge H; Kanehiro H; Tsutsumi M; Amanuma T; Iwata H; Yang J; Okano T; Nakajima Y
Nat Med; 2007 Jul; 13(7):880-5. PubMed ID: 17572687
[TBL] [Abstract][Full Text] [Related]
55. Primary hepatocyte survival on non-integrin-recognizable matrices without the activation of Akt signaling.
Hoshiba T; Nagahara H; Cho CS; Tagawa Y; Akaike T
Biomaterials; 2007 Feb; 28(6):1093-104. PubMed ID: 17081603
[TBL] [Abstract][Full Text] [Related]
56. Hepatic tissue engineering.
Kulig KM; Vacanti JP
Transpl Immunol; 2004 Apr; 12(3-4):303-10. PubMed ID: 15157923
[TBL] [Abstract][Full Text] [Related]
57. HEMET: mathematical model of biochemical pathways for simulation and prediction of HEpatocyte METabolism.
De Maria C; Grassini D; Vozzi F; Vinci B; Landi A; Ahluwalia A; Vozzi G
Comput Methods Programs Biomed; 2008 Oct; 92(1):121-34. PubMed ID: 18640740
[TBL] [Abstract][Full Text] [Related]
58. Investigation of metabolic objectives in cultured hepatocytes.
Uygun K; Matthew HW; Huang Y
Biotechnol Bioeng; 2007 Jun; 97(3):622-37. PubMed ID: 17058287
[TBL] [Abstract][Full Text] [Related]
59. Human hepatocyte functions in a crossed hollow fiber membrane bioreactor.
De Bartolo L; Salerno S; Curcio E; Piscioneri A; Rende M; Morelli S; Tasselli F; Bader A; Drioli E
Biomaterials; 2009 May; 30(13):2531-43. PubMed ID: 19185912
[TBL] [Abstract][Full Text] [Related]
60. Characteristic gene expression induced by polyurethane foam/spheroid culture of hepatoma cell line, Hep G2 as a promising cell source for bioartificial liver.
Shimada M; Yamashita Y; Tanaka S; Shirabe K; Nakazawa K; Ijima H; Sakiyama R; Fukuda J; Funatsu K; Sugimachi K
Hepatogastroenterology; 2007; 54(75):814-20. PubMed ID: 17591070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
